Big4Bio

16.8K posts

Big4Bio banner
Big4Bio

Big4Bio

@big4bio

Subscribe FREE for daily biohub news covering the Boston, San Diego, San Francisco, Philadelphia, Los Angeles, New York City, Capital Region, and Seattle areas.

San Francisco, CA Katılım Aralık 2013
2.5K Takip Edilen3.2K Takipçiler
Big4Bio
Big4Bio@big4bio·
As companies scale in uneven markets, leadership decisions are rarely just about who to hire. The bigger questions are: When? Why? And in what capacity? We’re sharing a thoughtful piece from @SlonePartners on building leadership for every stage of growth, and why executive search is only part of the story. For more than 25 years, they have partnered with biotech, diagnostics, healthtech, medtech, pharma, and specialized research services companies to: 🔹Sequence hires strategically as companies reach key milestones 🔹Ensuring leaders complement one another across functions 🔹Advising founders and boards on organizational design and succession 🔹Supporting both retained and fractional talent needs In life sciences and healthcare, leadership cohesion can be the difference between navigating an inflection point and missing it: bit.ly/4b10tf4
English
0
1
1
54
Big4Bio
Big4Bio@big4bio·
The journey from discovery to IND is rarely linear, and getting it right requires more than strong science alone. In the latest installment of Big4Bio’s ongoing podcast series with Charles River Laboratories, we explore how programs can be effectively de-risked before they advance to the clinic. 🎙️ We sat down with Manu Kohli, Principal Scientific Advisor at Charles River, to discuss the company’s One Step approach and how an integrated, end-to-end drug development model supports: • Rigorous target validation • Continuous regulatory engagement • Translationally relevant models • On-time, on-budget delivery of IND-ready assets 🎧 Tune in to learn more: soundcloud.com/big4bio/every-…
English
0
0
0
102
Big4Bio
Big4Bio@big4bio·
Did you miss our Special Pre-JPM Webinar Event yesterday? Don’t worry — you can still catch the full conversation. 👇 Big4Bio and The Sophia Consulting Firm hosted “Know Before You Go: AI in 2026 — Signals, Risks, and Real-World Impact,” bringing together more than 250 registrants for a candid, grounded discussion on how AI is actually showing up in life sciences right now. Key takeaways: • The AI signals already shaping JPM 2026 conversations • Where hype is fading — and where real-world impact is accelerating • How leaders are approaching AI, investment, and innovation with clarity and intention As we head into a pivotal year for thoughtful AI adoption, sharper partnerships, and real-world impact, this discussion offers a timely perspective for leaders navigating what’s next. 🎥 Watch the full webinar on YouTube: youtube.com/watch?v=tvNDDv…
YouTube video
YouTube
English
0
2
3
134
Big4Bio
Big4Bio@big4bio·
Big4Bio will be on the ground during #JPMWeek, and our CBO Dave Whelan will be attending several global-focused events throughout the week. We hope to see you there! Where to connect with Dave: 🔹 Connecting Clusters of Excellence: Europe as Your Gateway to Global Success Dave will join a panel on Redefining Women’s Health: Europe and the U.S. Unite to Power Innovation, Investment, and Impact. 👉 eventbrite.be/e/connecting-c… 🔹 Italy On The Move 👉 luma.com/iabw04lb?tk=FH… 🔹 6th Global IR @ JPM 2026 (KoreaBIO x Sidley Austin x BioCentury) 👉 eventbrite.com/e/the-6th-glob… You can also find Dave at BLPN, ABD Capital Connect, and connect with Marie Daghlian at the BioTech Showcase. Looking forward to strong global conversations and partnerships this JPM Week!
English
0
1
1
137
Big4Bio
Big4Bio@big4bio·
We’re officially three weeks away from our Special Pre-JPM Webinar Event, “Know Before You Go: AI in 2026 — Signals, Risks, and Real-World Impact.” Get ready for #JPMWeek as industry leaders come together to break down the AI trends shaping life sciences ahead of #JPM2026. Join us as we explore: 🔹 The AI and data trends expected to guide next year’s conversations 🔹 Lessons from 2025 influencing partnerships and investments 🔹 How human–AI collaboration is reshaping innovation 🔹 Practical insights for leaders navigating rapid change Featuring Panelists: Amit Gir, MD • Martha Lawrence • Saudat Adamson Fadeyi, PhD, MBA • Dan Gober • Karen Knudsen MBA PhD 🎙️ Hosted by Dr. Sophia Ononye Learn more & Register: luma.com/knowbeforeyougo #JPM2026 #JPM26 #Biotech #LifeSciences #Partnering #Biopharma #AI
English
1
3
2
225
Big4Bio retweetledi
LifeSci Startup
LifeSci Startup@LSciStartupNews·
Dren Bio partnered with $SNY in a $1.7B collaboration to develop new autoimmune therapies. This includes $100M upfront plus potential milestones, with Dren Bio able to co-fund development for U.S. co-promotion and share of profits, plus royalties ex-U.S. reuters.com/business/healt…
English
0
1
0
110
Big4Bio
Big4Bio@big4bio·
As the life sciences community prepares for #JPMWeek 2026, Biotech Showcase remains a central platform for companies seeking capital, partners, and industry visibility. Produced by Demy-Colton and EBD Group, Biotech Showcase is built to connect innovators with investors and strategic partners through curated programming and high-quality engagement. 📊 Recent activity highlights include: • 40% increase in meeting requests year-over-year • 59% growth in scheduled meetings • 28% more licensing opportunities published Register now & save 👉 informaconnect.com/biotech-showca…
Big4Bio tweet media
English
0
2
0
137
Big4Bio retweetledi
LifeSci Startup
LifeSci Startup@LSciStartupNews·
Kymera Therapeutics $KYMR closed an upsized public offering, raising ~$692M in gross proceeds to advance its oral small-molecule degrader platform for immunological diseases. globenewswire.com/news-release/2…
LifeSci Startup tweet media
English
0
1
0
94
Big4Bio
Big4Bio@big4bio·
In the next installment of our Discovery Sciences podcast series with Charles River Laboratories, we explore how AI and advanced computational tools are accelerating the path from idea to therapy. Charles River is pairing its deep discovery sciences expertise with technologies like the Logica AI platform and virtual control groups to speed development timelines, enhance safety, and further reduce animal use. In this episode, we’re joined by Alison Jones, Senior Science Director, and Laura L., Director of Digital Product Management, Discovery & Safety Assessment, who share insights on: 🔹 The role of AI in transforming early discovery 🔹 Why high-quality data is becoming a key competitive edge 🔹 How human scientific judgment remains essential amid automation 🎧 Listen now to see how computational tools and expert insight are shaping the future of therapeutic innovation: soundcloud.com/big4bio/every-…
English
0
0
0
97
Big4Bio
Big4Bio@big4bio·
Never miss a key moment in biotech with Big4Bio’s BioCalendar! From top conferences to essential partnering events and investor meetings, the BioCalendar puts the industry’s must-attend events right at your fingertips. ⚡ Discover and track major life science events worldwide ⚡ Promote your own conferences and meetings ⚡ Stay connected with the biotech community all year long Planning your 2026 travel or looking to increase visibility for your event? The BioCalendar makes it simple to stay ahead. 🔗 Check out upcoming events here: thebiocalendar.com
Big4Bio tweet media
English
0
0
0
50
Big4Bio retweetledi
LifeSci Startup
LifeSci Startup@LSciStartupNews·
Formation Bio has signed a deal worth up to $605M for ex-China rights to Lynk Pharma’s LNK01006, a CNS-penetrant allosteric TYK2 inhibitor for autoimmune and inflammatory diseases. fiercebiotech.com/biotech/bleeke…
English
0
1
0
47
Big4Bio retweetledi
LifeSci Startup
LifeSci Startup@LSciStartupNews·
PsiThera has spun out of Roivant with $47M in Series A funding and its QUAISAR™ platform that uses physics, AI, and supercomputing to accelerate early drug discovery before lab work begins. Roivant continues to back the company. More: cen.acs.org/pharmaceutical…
LifeSci Startup tweet media
English
0
1
0
70
Big4Bio
Big4Bio@big4bio·
🚨 Don't miss out! Our upcoming webinar, Know Before You Go: AI in 2026 - Signals, Risks, and Real-World Impact, brings together experts across pharma, AI, clinical research, immunology, and innovation strategy to break down where AI is making the biggest impact today, and what stakeholders need to know heading into the new year and #JPM2026. From real-world applications to investment and partnership implications, this session delivers timely, practical insights you won’t want to miss. 🎙️ Hosted by Dr. Sophia Ononye 🎤 Featuring leaders from The Parker Institute, Biocom California, Samyang Biopharm USA, AccendoWave, and Phox Health Save your spot and get ready for one of the most important conversations leading into JPM Week: luma.com/knowbeforeyougo
English
0
1
0
55